Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ELUT | Elutia Inc.

Healthcare | Medical Devices | USA | NASD

Index	-	P/E	-	EPS (ttm)	-2.25	Insider Own	0.70%	Shs Outstand	16.22M	Perf Week	42.48%
Market Cap	26.65M	Forward P/E	-	EPS next Y	-1.43	Insider Trans	120.85%	Shs Float	6.08M	Perf Month	0.00%
Income	-33.90M	PEG	-	EPS next Q	-0.56	Inst Own	28.70%	Short Float / Ratio	1.03% / 0.16	Perf Quarter	-33.20%
Sales	48.40M	P/S	0.55	EPS this Y	0.00%	Inst Trans	-0.13%	Short Interest	0.06M	Perf Half Y	31.97%
Book/sh	-1.36	P/B	-	EPS next Y	32.90%	ROA	-55.90%	Target Price	8.00	Perf Year	-76.50%
Cash/sh	0.56	P/C	2.87	EPS next 5Y	-	ROE	271.50%	52W Range	1.10 - 9.01	Perf YTD	-62.12%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-164.60%	52W High	-82.13%	Beta	-0.12
Dividend %	-	Quick Ratio	0.60	Sales past 5Y	-	Gross Margin	35.90%	52W Low	46.36%	ATR	0.21
Employees	151	Current Ratio	0.80	Sales Q/Q	-18.30%	Oper. Margin	-66.20%	RSI (14)	56.16	Volatility	17.41% 13.98%
Optionable	No	Debt/Eq	-	EPS Q/Q	5.10%	Profit Margin	-70.10%	Rel Volume	3.60	Prev Close	1.65
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 14 AMC	Payout	-	Avg Volume	396.99K	Price	1.61
Recom	2.00	SMA20	15.81%	SMA50	-8.39%	SMA200	-41.12%	Volume	1,427,829	Change	-2.42%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-02-20	Initiated	Truist	Buy	$20
Nov-02-20	Initiated	Piper Sandler	Overweight	$20
Nov-02-20	Initiated	Cowen	Outperform	$20
Nov-02-20	Initiated	Cantor Fitzgerald	Overweight	$20

Sep-20-23 08:30AM	Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-19-23 08:36AM	Elutia Announces Private Placement for Proceeds Up to $26 Million (GlobeNewswire) +33.06%
Sep-18-23 04:08PM	Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million (GlobeNewswire) +9.73%
Sep-08-23 08:30AM	Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire) -7.27%
Sep-06-23 04:05PM	Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices (GlobeNewswire)
08:30AM	Loading…
Aug-30-23 08:30AM	Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures (GlobeNewswire) +6.29%
Aug-21-23 09:42AM	Aziyo Biologics, Inc. (NASDAQ:AZYO) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-15-23 05:21AM	Q2 2023 Aziyo Biologics Inc Earnings Call (Thomson Reuters StreetEvents) +6.72%
Aug-14-23 04:05PM	Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company (GlobeNewswire)
Jul-31-23 04:05PM	Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 (GlobeNewswire)
Jul-26-23 03:29PM	CDC, health agencies investigate amid Aziyo Biologics' voluntary recall of bone repair product following TB infections (American City Business Journals)
Jul-17-23 04:05PM	SWK Holdings Highlights Recent Achievements and Provides Portfolio Update (PR Newswire)
Jul-13-23 04:30PM	Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products (GlobeNewswire)
May-19-23 01:45PM	Aziyo Biologics Presents Clinical Data On CanGaroo Biologic Envelope In Patients Receiving Cardiac Implantable Electronic Devices (Benzinga)
08:15AM	Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope (GlobeNewswire)
08:17AM	Loading…
May-13-23 08:17AM	One Forecaster Is Now More Bearish On Aziyo Biologics, Inc. (NASDAQ:AZYO) Than They Used To Be (Simply Wall St.)
May-11-23 09:58AM	Dr. Reddy's (RDY) Q4 Earnings and Revenues Beat Estimates (Zacks) -7.69%
05:51AM	Q1 2023 Aziyo Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
May-10-23 04:05PM	Aziyo Biologics Reports Highest Sales and Gross Profit in Company History (GlobeNewswire)
May-03-23 04:05PM	Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023 (GlobeNewswire) +8.44%
10:42AM	Q1 2023 LeMaitre Vascular Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-20-23 04:30PM	Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyos Cardiovascular Portfolio (GlobeNewswire)
Apr-17-23 06:11AM	Why Investors Shouldn't Be Surprised By Aziyo Biologics, Inc.'s (NASDAQ:AZYO) 63% Share Price Plunge (Simply Wall St.)
Apr-05-23 09:55AM	Aziyo Biologics, Inc. (AZYO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Mar-27-23 06:26AM	Aziyo Biologics, Inc. (NASDAQ:AZYO) Q4 2022 Earnings Call Transcript (Insider Monkey) +22.45%
Mar-23-23 06:08AM	Q4 2022 Aziyo Biologics Inc Earnings Call (Thomson Reuters StreetEvents) +17.65%
Mar-22-23 04:01PM	Aziyo Biologics Reports Record Full Year 2022 Revenues (GlobeNewswire)
08:30AM	Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Womens Access to Biologics for Soft Tissue Reconstruction (GlobeNewswire)
Mar-20-23 12:01PM	ACER's Stock Down on Failure of Phase II Study, Cash Updates (Zacks) -62.82%
08:00AM	Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial Envelope (GlobeNewswire)
04:05PM	Loading…
Mar-15-23 04:05PM	Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023 (GlobeNewswire)
Feb-27-23 08:15AM	Aziyo Biologics to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire) -7.56%
Jan-31-23 08:00AM	SWK Holdings Provides Portfolio Update Highlighting Recent Achievements (PR Newswire)
Jan-26-23 12:00PM	Aziyo Biologics, Inc. (AZYO) Upgraded to Buy: Here's What You Should Know (Zacks) -10.00%
09:40AM	Are Medical Stocks Lagging Bionano Genomics (BNGO) This Year? (Zacks)
Jan-21-23 09:58AM	Investors in Aziyo Biologics (NASDAQ:AZYO) have unfortunately lost 38% over the last year (Simply Wall St.)
Jan-09-23 08:15AM	Aziyo Biologics Announces Record Annual Net Sales in Preliminary (Unaudited) Fourth Quarter and Full Year 2022 Topline Results (GlobeNewswire) -7.07%
Dec-15-22 08:00AM	Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings Corporation (GlobeNewswire)
Dec-10-22 07:38AM	Chief Financial Officer Matthew Ferguson Just Bought 79% More Shares In Aziyo Biologics, Inc. (NASDAQ:AZYO) (Simply Wall St.)
Dec-01-22 09:04AM	Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock (GlobeNewswire) -40.58%
Nov-30-22 04:08PM	Aziyo Biologics, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Nov-21-22 04:05PM	Aziyo Biologics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-16-22 06:00AM	Aziyo Biologics Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-14-22 05:25PM	Aziyo Biologics, Inc. (AZYO) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Aziyo Biologics Reports Strong Third Quarter 2022 Revenue (GlobeNewswire)
Nov-07-22 04:05PM	Aziyo Biologics to Report Third Quarter 2022 Financial Results on November 14, 2022 (GlobeNewswire)
07:40AM	While individual investors own 33% of Aziyo Biologics, Inc. (NASDAQ:AZYO), private equity firms are its largest shareholders with 36% ownership (Simply Wall St.)
Oct-25-22 09:47AM	Aziyo Biologics, Inc. (AZYO) Soars 11.7%: Is Further Upside Left in the Stock? (Zacks)
Oct-24-22 08:00AM	Aziyo Biologics Appoints Seasoned Healthcare Executive, David Colpman, to Board of Directors (GlobeNewswire) +11.71%
Oct-18-22 04:05PM	SWK Holdings Provides Portfolio Update Highlighting Recent Achievements (PR Newswire)
Oct-11-22 04:35PM	Aziyo Biologics Strengthens Leadership Team and Organizes for Growth in Key Markets (GlobeNewswire) -5.61%
07:44AM	Great news for Aziyo Biologics, Inc. (NASDAQ:AZYO): Insiders acquired stock in large numbers last year (Simply Wall St.)
Aug-26-22 09:00AM	Aziyo Biologics Appoints Michelle LeRoux Williams, Ph.D as Chief Scientific Officer (GlobeNewswire)
Aug-17-22 04:05PM	Aziyo Biologics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase (GlobeNewswire) +8.99%
Aug-16-22 01:53PM	Aziyos new CEO wants to build the company into 'an engine.' Heres his vision. (American City Business Journals)
Aug-14-22 10:16AM	Aziyo Biologics (NASDAQ:AZYO) shareholders have endured a 19% loss from investing in the stock a year ago (Simply Wall St.)
Aug-11-22 04:05PM	Aziyo Biologics Announces Second Quarter 2022 Financial Results and Recent Business Achievements, Including Robust Revenue Growth and Strengthened Balance Sheet (GlobeNewswire)
03:09PM	Silver Spring biotech names new CEO (American City Business Journals)
Aug-10-22 06:56PM	Aziyo Biologics Announces $25 Million Loan Facility with SWK Holdings (GlobeNewswire)
Aug-09-22 05:58PM	Aziyo Biologics Co-Founder and Regenerative Medicine Pioneer, Dr. Randy Mills, appointed Chief Executive Officer (GlobeNewswire)
Jul-28-22 04:05PM	Aziyo Biologics to Report Second Quarter 2022 Financial Results on August 11, 2022 (GlobeNewswire) +5.53%
Jul-20-22 09:40AM	Is Aziyo Biologics (AZYO) Outperforming Other Medical Stocks This Year? (Zacks)
Jun-27-22 04:15AM	Aziyo Biologics, Inc. (AZYO) Moves 7.8% Higher: Will This Strength Last? (Zacks)
Jun-21-22 04:05PM	Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO (GlobeNewswire)
Jun-01-22 08:50AM	Stonegate Capital Partners Updates Coverage On Aziyo Biologics, Inc. (Nasdaq:AZYO) (ACCESSWIRE)
May-09-22 05:25PM	Aziyo Biologics, Inc. (AZYO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Aziyo Biologics Provides Business Update and Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-02-22 08:21AM	Quite a few insiders invested in Aziyo Biologics, Inc. (NASDAQ:AZYO) last year which is positive news for shareholders (Simply Wall St.) -7.38%
Apr-25-22 04:05PM	Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 (GlobeNewswire) +5.02%
Apr-12-22 04:05PM	Aziyo Biologics Announces Upcoming KOL Call Hosted by Cowen (GlobeNewswire)
Apr-04-22 08:00AM	Aziyo Announces FDA 510(k) Submission for CanGaroo® RM, its Next-Generation Biomaterial Envelope Enhanced with Antibiotics (GlobeNewswire)
Mar-31-22 06:50PM	Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference (GlobeNewswire)
Mar-11-22 08:30AM	Stonegate Capital Partners Updates Coverage On Aziyo Biologics, Inc. (Nasdaq:AZYO) (ACCESSWIRE) -13.70%
Mar-07-22 06:40AM	Investors one-year losses grow to 56% as the stock sheds US$10m this past week (Simply Wall St.) -15.89%
Mar-04-22 09:28AM	Analysts Cut Price Target On Aziyo Biologics As Q4 Earnings Fall Short Of Expectations (Benzinga) +6.96%
Mar-03-22 06:25PM	Aziyo Biologics, Inc. (AZYO) Reports Q4 Loss, Lags Revenue Estimates (Zacks) -10.28%
04:01PM	Aziyo Biologics Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Feb-23-22 04:01PM	Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference (GlobeNewswire)
Feb-17-22 04:01PM	Aziyo Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022 (GlobeNewswire) +5.50%
Feb-14-22 12:00PM	All You Need to Know About Aziyo Biologics, Inc. (AZYO) Rating Upgrade to Buy (Zacks) -6.55%
09:40AM	Has Aziyo Biologics, Inc. (AZYO) Outpaced Other Medical Stocks This Year? (Zacks)
Jan-18-22 08:45AM	Stonegate Capital Partners Initiates Coverage on Aziyo Biologics, Inc. (NASDAQ:AZYO) (ACCESSWIRE) -8.93%
Jan-11-22 10:00AM	Wall Street Analysts See a 123% Upside in Aziyo Biologics, Inc. (AZYO): Can the Stock Really Move This High? (Zacks) +7.66%
Dec-27-21 04:01PM	Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference (GlobeNewswire) -6.90%
Dec-08-21 05:31PM	Aziyo Biologics Announces Closing of $14.0 Million Private Placement (GlobeNewswire) +25.56%
Dec-06-21 06:59AM	Aziyo Biologics Announces $14.0 Million Private Placement (GlobeNewswire)
Nov-15-21 04:05PM	Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences (GlobeNewswire)
Nov-09-21 05:25PM	Aziyo Biologics, Inc. (AZYO) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Aziyo Biologics Reports Third Quarter 2021 Financial Results (GlobeNewswire)
Nov-02-21 03:02PM	Will Aziyo Biologics, Inc. (AZYO) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-26-21 08:30AM	The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children (Benzinga) +8.36%
Oct-25-21 04:01PM	Aziyo Biologics Provides Business Update and Preliminary Third Quarter 2021 Revenue Results and Announces Timing for Third Quarter 2021 Financial Results (GlobeNewswire)
Sep-15-21 04:05PM	Aziyo Biologics to Participate in the 2021 Cantor Global Healthcare Conference (GlobeNewswire)
Aug-31-21 04:05PM	Aziyo Biologics Appoints Peter G. Edwards as General Counsel (GlobeNewswire)
Aug-15-21 03:05AM	The Aziyo Biologics, Inc. (NASDAQ:AZYO) Second-Quarter Results Are Out And Analysts Have Published New Forecasts (Simply Wall St.)
Aug-09-21 04:01PM	Aziyo Biologics Reports Second Quarter 2021 Financial Results (GlobeNewswire)
Jul-26-21 04:01PM	Aziyo Biologics to Report Second Quarter 2021 Financial Results on Monday, August 9, 2021 (GlobeNewswire)
Jun-30-21 09:34AM	Is Aziyo Biologics, Inc. (AZYO) Going to Burn These Hedge Funds? (Insider Monkey) -6.34%
Jun-10-21 01:30AM	Are Insiders Buying Aziyo Biologics, Inc. (NASDAQ:AZYO) Stock? (Simply Wall St.)
Jun-07-21 08:00AM	Aziyo Biologics Comments on June 2nd Voluntary Recall of One Lot of its FiberCel Fiber Viable Bone Matrix (GlobeNewswire) -9.08%

Elutia Inc., a commercial-stage company, engages in developing and commercializing drug-eluting biomatrix technology to enhance surgical outcomes. It offers CanGaroo Envelope, which is used for the stabilization of implantable cardiac devices, such as pacemakers and defibrillators. The company also engages in the development of CanGaroo RM for delivery directly to the surgical site. In addition, it offers SimpliDerm Acellular Dermal Matrix used primarily in breast reconstruction following mastectomy. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mills C Randal	PRESIDENT AND CEO	Apr 27	Option Exercise	0.00	44,947	0	48,008	Apr 28 05:31 PM
Birchview Capital, LP	10% Owner	Mar 27	Buy	1.59	10,000	15,870	1,655,184	Mar 27 04:17 PM
Birchview Capital, LP	10% Owner	Mar 24	Buy	1.35	20,000	27,078	1,645,184	Mar 27 04:17 PM
Birchview Capital, LP	10% Owner	Mar 23	Buy	1.49	110,000	164,010	1,625,184	Mar 27 04:17 PM
Englese Thomas	CHIEF COMMERCIAL OFFICER	Mar 09	Sale	4.30	289	1,243	17,917	Mar 09 09:18 PM
Englese Thomas	CHIEF COMMERCIAL OFFICER	Mar 08	Option Exercise	0.00	937	0	18,206	Mar 09 09:18 PM
Ferguson Matthew	CHIEF FINANCIAL OFFICER	Mar 08	Option Exercise	0.00	1,287	0	46,504	Mar 09 09:11 PM
Colpman David	Director	Dec 15	Buy	3.90	3,098	12,082	3,098	Dec 16 04:46 PM
Makes Brigid	Director	Dec 09	Buy	3.65	2,000	7,300	2,000	Dec 12 05:08 PM
Birchview Capital, LP	10% Owner	Dec 08	Buy	3.79	13,061	49,518	1,515,184	Feb 13 07:01 PM
Birchview Capital, LP	10% Owner	Dec 07	Buy	3.58	44,000	157,520	1,502,123	Feb 13 07:01 PM
HighCape Capital, L.P.	Director	Dec 05	Buy	4.75	735,000	3,491,250	5,597,604	Dec 07 04:31 PM
Ferguson Matthew	CHIEF FINANCIAL OFFICER	Dec 05	Buy	4.65	22,000	102,220	45,217	Dec 05 08:44 PM
Ferguson Matthew	CHIEF FINANCIAL OFFICER	Dec 02	Buy	4.03	6,000	24,180	23,217	Dec 05 08:44 PM
Birchview Capital, LP	10% Owner	Dec 01	Buy	4.75	40,000	190,000	1,458,123	Feb 13 07:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ELUT | Elutia Inc.

Upgrade your FINVIZ experience